Cargando…
An optimized Nurr1 agonist provides disease-modifying effects in Parkinson’s disease models
The nuclear receptor, Nurr1, is critical for both the development and maintenance of midbrain dopamine neurons, representing a promising molecular target for Parkinson’s disease (PD). We previously identified three Nurr1 agonists (amodiaquine, chloroquine and glafenine) that share an identical chemi...
Autores principales: | Kim, Woori, Tripathi, Mohit, Kim, Chunhyung, Vardhineni, Satyapavan, Cha, Young, Kandi, Shamseer Kulangara, Feitosa, Melissa, Kholiya, Rohit, Sah, Eric, Thakur, Anuj, Kim, Yehan, Ko, Sanghyeok, Bhatia, Kaiya, Manohar, Sunny, Kong, Young-Bin, Sindhu, Gagandeep, Kim, Yoon-Seong, Cohen, Bruce, Rawat, Diwan S., Kim, Kwang-Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354055/ https://www.ncbi.nlm.nih.gov/pubmed/37463889 http://dx.doi.org/10.1038/s41467-023-39970-9 |
Ejemplares similares
-
NSC 18725, a Pyrazole Derivative Inhibits Growth of Intracellular Mycobacterium tuberculosis by Induction of Autophagy
por: Arora, Garima, et al.
Publicado: (2020) -
Potent synthetic and endogenous ligands for the adopted orphan nuclear receptor Nurr1
por: Jang, Yongwoo, et al.
Publicado: (2021) -
Chloroquine modulates inflammatory autoimmune responses through Nurr1 in autoimmune diseases
por: Park, Tae-Yoon, et al.
Publicado: (2019) -
Nurr1 (NR4A2) regulates Alzheimer’s disease‐related pathogenesis and cognitive function in the 5XFAD mouse model
por: Moon, Minho, et al.
Publicado: (2018) -
Pharmacological Stimulation of Nurr1 Promotes Cell Cycle Progression in Adult Hippocampal Neural Stem Cells
por: Moon, Haena, et al.
Publicado: (2019)